Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Reproductive Health
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Postpartum Contraception Uptake Remains Low Despite Clear Benefits
January 2026
New data show that many women do not receive effective contraception in the postpartum period, highlighting missed opportunities in reproductive healthcare.
Read more
4 May 2017
AlzProtect : The American Food and Drug Administration (FDA) Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)
The American Food and Drug Administration (FDA) has granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)
11 Apr 2017
LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay
Konstanz/Berlin, Germany, April 11, 2017 – LifeCodexx AG, a leading European NIPT provider, and the Department of Obstetrics of the Charité have formed a…
5 Apr 2017
Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets
Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
6 Mar 2017
New Results from Second Phase 3 Study Show Significant Efficacy of Guselkumab and Superiority Versus Humira® in Treatment of Moderate to Severe Plaque Psoriasis
Orlando, Florida, 3 March, 2017 ― Janssen Research & Development, LLC (Janssen) announced today new findings from two pivotal Phase 3 studies reporting…
23 Jan 2017
NLRP2 Protein Found to Influence Fertility
A PROTEIN, known as NLRP2, has been found to play a key role in early embryogenesis and affect maternal fertility later in life in animal models. As a…
23 Jan 2017
Fathers’ Preconception Phthalate Exposure May Influence Embryonic Development
PRECONCEPTION paternal exposure to phthalates, compounds found in plastics and personal products and estimated to be detectable in almost the entire…
16 Jan 2017
Recommendations Made for Patients Struggling to Sleep
AGE UK, a British charity, have released a report making a series of recommendations for healthcare providers in their approach to treating patients…
10 Jan 2017
Introducing EMJ Innovations 1.1
United Kingdom, January 10, 2017: Happy new year and welcome to our first journal of the year, the inaugural edition of the European Medical Journal…
Loading posts...
« Previous
1
…
32
33
34
35
36
…
38
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View